GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹91 Cr | ₹64 Cr | ₹39 Cr | ₹40 Cr | ₹11 Cr |
What is the latest Cash Flow from Operating Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹91 Cr |
| Mar2024 | ₹64 Cr |
| Mar2023 | ₹39 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹11 Cr |
How is Cash Flow from Operating Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹91 Cr | 41.76 | |
| Mar2024 | ₹64 Cr | 62.66 | |
| Mar2023 | ₹39 Cr | -2.08 | |
| Mar2022 | ₹40 Cr | 282.80 | |
| Mar2021 | ₹11 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹3,613.9 Cr | 6.6% | -23.9% | 6.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,559.0 Cr | 7.1% | -1.5% | -6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,827.0 Cr | 2.8% | -2.8% | 6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,942.0 Cr | 3.1% | 4.2% | 18.8% | Stock Analytics | |
| CIPLA | ₹106,825.0 Cr | 0.2% | -12.5% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,077.0 Cr | 2.2% | -1.6% | 0% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 6.6% |
-23.9% |
6.5% |
| SENSEX | 1.7% |
-1.7% |
10.3% |
You may also like the below Video Courses